NCT01499043 Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC) Status TERMINATED Phase PHASE2
NCT01496885 Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke Status COMPLETED Phase N/A
NCT01496365 Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy Status COMPLETED Phase PHASE2
NCT01476696 A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT01468467 A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1
NCT01390337 A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1
NCT01364844 Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors Status COMPLETED Phase PHASE1
NCT01349049 Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1/PHASE2
NCT01349036 A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma Status TERMINATED Phase PHASE2
NCT01345019 Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01327534 Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI Status COMPLETED Phase PHASE3
NCT01290471 Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors Status COMPLETED Phase PHASE1
NCT01288430 A Study of DS-2248 in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT01287858 Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01260584 The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease Status COMPLETED Phase PHASE4
NCT01245543 Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors Status WITHDRAWN Phase PHASE1
NCT01244191 Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Status TERMINATED Phase PHASE3
NCT01220999 A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1